LONDON (Reuters) - GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million (574 million pounds) , following a long investment in the firm.
Friday 13 March 2015
0 comments:
Post a Comment